Access Evidence Lead

Chez Roche, vous pouvez être vous-même et être apprécié pour les qualités uniques que vous apportez. Notre culture encourage l'expression personnelle, le dialogue ouvert et les connexions authentiques, où vous êtes valorisé, accepté et respecté pour ce que vous êtes, vous permettant de prospérer tant personnellement que professionnellement. Voici comment nous visons à prévenir, arrêter et guérir les maladies et à garantir à chacun l'accès aux soins de santé aujourd'hui et pour les générations à venir.

Rejoignez Roche, où chaque voix compte.

At Roche, we are passionate about transforming patients' lives. We are brave in both decision and action and believe that good business means a better world. That is why we come to work each day. We commit ourselves to scientific rigor, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow. The Global Access (GA) organization is a key part of this mission.

We are seeking a dedicated Access Evidence Lead to join our RWE and Post-Launch pod, a specialized team focused on ensuring our medicines remain accessible to patients throughout their entire lifecycle. This is a unique opportunity to shape and sustain the value of our in-market medicines through evidence as an individual contributor in a dual-responsibility role.

• RWE Strategy & Execution: Identify critical launch and post-launch evidence gaps, design robust RWE studies to fill them, and collaborate closely with global and affiliate colleagues on study design, execution, and dissemination of results.
• HTA Deliverable Management: Take ownership of and update core global HTA deliverables—including cost-effectiveness models (CEMs), budget impact models (BIMs), systematic literature reviews (SLRs), indirect treatment comparisons (ITCs), and Global Value Dossiers (GVDs)-for established medicines (2-3 years after launch).
• Affiliate Partnership: Act as the primary technical partner for affiliates in later-launching countries or those facing access re-negotiations, providing hands-on support to update HTA deliverables to meet specific needs and assisting with answering technical questions from HTA bodies and payers.
• Cross-Functional Collaboration: Work seamlessly with colleagues across Global Access, Medical Affairs, Commercial, Product Development Data, Real-World Data, and affiliates to deliver integrated evidence solutions in a highly collaborative, global matrix environment.
• Technical Expertise: Serve as a strategic expert and subject-matter expert on the application of RWE for market access and on updating HTA deliverables for lifecycle management to ensure continued patient access.

• Education: You hold a Master's or doctoral-level degree (MSc, PhD, PharmD) in a quantitative discipline such as Health Economics, Epidemiology, Statistics, or Public Health.
• Experience: You have at least 5 years of relevant experience in the pharmaceutical industry, a health technology assessment agency, or a HEOR consultancy.
• Hands-on Expertise: You have demonstrated experience in designing and implementing RWE studies for market access, developing/adapting health economic models (CEMs, BIMs), conducting SLRs/ITCs, and supporting HTA submissions while responding to questions from HTA bodies.
• Technical &
  
  Soft Skills:
  
  You possess strong analytical skills, proficiency with relevant software (e.g., R for statistical analysis; MS Excel including VBA for economic modeling), and are an excellent communicator and collaborator.
• Mindset: You are a proactive, solution-oriented professional driven by scientific innovation and passionate about demonstrating product value through evidence to make a meaningful impact for patients through teamwork.

Where…